AMBEST PHARMACEUTICAL (CHINA)
Ambest Pharmaceutical (China) is engaged in the manufacturing of large volume injectables, and research, technology transfer and technology services of pharmaceutical products. It currently holds the drug production approvals of monoammonium glycyrrhizinate and cysteine and sodium chloride injection and floium Ginkgo extract and tertram rthypyrazine sodium chloride injection.
AMBEST PHARMACEUTICAL (CHINA)
Industry:
Biotechnology Manufacturing Pharmaceutical
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Similar Organizations
Ambee
Ambee manufactures a pharmaceutical products.
Aspire India
Aspire India manufactures pharmaceutical equipment.
Braintree Laboratories
Braintree Laboratories manufactures pharmaceutical products.
Huaren Pharmaceutical
Huaren Pharmaceutical manufactures pharmaceutical products.
Kanghui Pharmaceutical
Shaanxi Kanghui Pharmaceutical manufactures pharmaceutical products.
Lee Pharma
Lee Pharma manufactures pharmaceutical products.
Scott-Edil Pharmacia
Scott-Edil Pharmacia manufactures pharmaceutical products.
The Arab Pharmaceutical Manufacturing Co. Ltd.
The Arab Pharmaceutical Manufacturing Co. Ltd. manufactures pharmaceutical products.
More informations about "Ambest Pharmaceutical (China)"
Ambest Pharmaceutical (China) Company - PitchBook
Ambest Pharmaceutical (China) Company General Information Description. Manufacturer of pharmaceutical products. The company's pharmaceutical products include injections, cysteine …See details»
Ambest Pharmaceutical (China) Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ambest Pharmaceutical (China) Co., Ltd. of Meihekou, Jilin. Get the latest business insights from Dun …See details»
Ambest Pharma - Products, Competitors, Financials, Employees ...
Ambest Pharmaceutical is engaged in the manufacturing of large volume injections, and research, technology transfer and technology services of pharmaceutical products. Use the CB Insights …See details»
Ambest Pharmaceutical (China) - Drug pipelines, Patents, Clinical ...
Explore Ambest Pharmaceutical (China) with its drug pipeline, therapeutic area, technology platform, . Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last …See details»
Sihuan Pharma Acquires Ambest Pharma China for $160 Million
Mar 23, 2017 Sihuan Pharma, headquartered in Beijing, will pay $160 million to acquire Ambest Pharma of China, a maker of large volume injection products. Ambest offers saline (sodium …See details»
Sihuan Pharma to acquire fellow Chinese drug firm
Mar 27, 2017 China’s Sihuan Pharmaceutical says that its wholly-owned subsidiary Sun Moral International (HK) has entered into an equity acquisition agreement with Ambest …See details»
Sihuan Pharmaceutical Acquires Ambest Pharma China For $160
Mar 24, 2017 Since its $742 million Hong Kong IPO in 2010, Sihuan has been an active participant in China pharma M&A while also developing a robust R&D pipeline. The company …See details»
Sihuan Pharmaceutical acquires Ambest Pharmaceutical (China)
Mar 27, 2017 Sihuan Pharmaceutical acquires Ambest Pharmaceutical (China) on 2017-03-27 for $160082660. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
China's Pharma Giants: Top 10 Biggest Pharmaceutical …
Sep 22, 2023 Sinopharm is a giant in China’s pharmaceutical landscape, boasting revenues upwards of $40 billion. Founded in 2003, it has quickly grown to become a leader in biopharmaceuticals and healthcare services. API …See details»
Sihuan Pharmaceutical Acquires Ambest Pharma China For $160 ... - BioSpace
Mar 24, 2017 Sihuan Pharmaceutical Acquires Ambest Pharma China For $160 Million. March 24, 2017 ...See details»
Top 10 Chinese Pharma Companies - PharmaBoardroom
Aug 11, 2019 China’s booming pharmaceutical industry has been rapidly expanding to become the second largest pharmaceutical market globally. The following are the top ten Chinese pharma companies from 2018, with …See details»
Unlocking China’s pharma market - PwC
Feb 27, 2024 Large and growing market: China’s significant and ageing population, estimated to be about 1.41 billion in 2021, presents a substantial market for pharmaceutical companies. By …See details»
Vision 2028: How China could impact the global biopharma industry
Property Organization (WIPO). In addition, 50 senior executives, most of whom work for biopharma companies, shared insights for the article. We also sought the views of ... 2015 …See details»
China: largest pharmaceutical companies by assets 2023 - Statista
Aug 21, 2023 According to the annual ranking of Forbes Global 2000 which measures the world's largest public companies, Sinopharm Group ranked first among Chinese …See details»
The US is relying more on China for pharmaceuticals — and vice …
Apr 20, 2023 For example, by some estimates, China supplies India—the US’ fifth largest source of pharmaceutical imports—with nearly 70% of its APIs. A mapping effort that traces the full supply chain of critical pharmaceuticals could reveal other areas of indirect risk that China could effectively leverage if the bilateral relationship substantially deteriorates.See details»
Chinese Pharma: A Global Health Game Changer?
Mar 31, 2015 Tapping into China’s low-cost, skilled labor, contract research organizations (CROs) providing research support to the pharmaceutical, biotech, and medical device …See details»
Ambest Pharmaceutical Co. Ltd. - Drug pipelines, Patents, Clinical ...
Jul 30, 2024 Explore Ambest Pharmaceutical Co. Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Insight Magazine | No Easy Cure: Western drug companies face …
Nov 20, 2019 As for the China market’s landscape in 20 years’ time, Chinese companies will dominate, absolutely. The strong Western MNCs in China will be those who choose the right …See details»
AM Best's Lee: China Outlook Shaped by Premiums, Profitability …
Feb 2, 2021 AM Best's Lee: China Outlook Shaped by Premiums, Profitability and Regulation. Christie Lee, senior director of analytics for Northeast Asia, AM Best, said AM Best is …See details»